Series B - Cognito Therapeutics - 2023-03-22 - Crunchbase

Mar 22, 2023 · Built In Boston — Cognito Raises $73M to Combat Alzheimer’s Disease. News • Mar 22, 2023. Business Wire — Cognito Therapeutics Raises $73M Series B to Advance …

CouponFollow Extension

$73
OFF

Series B - Cognito Therapeutics - 2023-03-22 - Crunchbase

6 days from now

Mar 22, 2023 · Built In Boston — Cognito Raises $73M to Combat Alzheimer’s Disease. News • Mar 22, 2023. Business Wire — Cognito Therapeutics Raises $73M Series B to Advance …

crunchbase.com

$73000000
OFF

Founder Lodge | Cognito Therapeutics, Inc. Raises $73,000,000 At …

6 days from now

Mar 23, 2023 · Cognito Therapeutics, Inc. raises $73,000,000 at Series B on 2023-03-23 in Medical Equipment Manufacturing, industry founded/co-founded by Brent Vaughan. Daily …

founderlodge.com

$73
OFF

Firm Advises Cognito Therapeutics On $73 Million Series B Financing

6 days from now

Client Highlights. March 31, 2023. On March 22, 2023, neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led by …

wsgr.com

$73
OFF

Cognito Therapeutics Raises $73M In Series B | Citybiz

6 days from now

March 22, 2023. CAMBRIDGE, Mass.– ( BUSINESS WIRE )– Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, …

citybiz.co

$73
OFF

Cognito Therapeutics Raises $73M Series B To Advance

6 days from now

Mar 22, 2023 · Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by …

financialcontent.com

$73
OFF

Cognito Therapeutics Raises $73M In Series B Funding For …

6 days from now

Mar 23, 2023 · Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, has completed a $73M Series B financing round led by …

mpo-mag.com

$73
OFF

Cognito Therapeutics Raises $73M In Series B Funding

6 days from now

Mar 22, 2023 · Cognito Therapeutics Raises $73M in Series B Funding. Pubblicato il 22 Marzo 2023 da CashInvoice. 22 Mar. USA – ...

cashinvoice.it

$118.25
OFF

Cognito Therapeutics Stock Price, Funding, Valuation, Revenue ...

6 days from now

Jul 2, 2024 · Funding, Valuation & Revenue. Cognito Therapeutics has raised $118.25M over 5 rounds. Cognito Therapeutics's latest funding round was a Series B - III for $10.25M on July 2, …

cbinsights.com

$73
OFF

Cognito Therapeutics Raises $73M Series B To Advance

6 days from now

Mar 22, 2023 12:14 UTC. COGNITO THERAPEUTICS RAISES $73M SERIES B TO ADVANCE NEUROTECHNOLOGY PLATFORM FOR ALZHEIMER’S DISEASE. COGNITO …

tradingview.com

$123000000
OFF

Series B - Flare Therapeutics - 2023-03-22 - Crunchbase

6 days from now

Mar 22, 2023 · Flare Therapeutics raised $123000000 on 2023-03-22 in Series B. Search Crunchbase. Start Free Trial ... Summary. Overview. Edit Overview Section. Organization …

crunchbase.com

$73
OFF

The Week’s 10 Biggest Funding Rounds: Benefits Startup Gravie …

6 days from now

Mar 24, 2023 · Founded in 2021, this is Artera’s first outside funding round, per Crunchbase data. 6. Cognito Therapeutics, $73M, biotech: Cambridge, Massachusetts-based Cognito …

crunchbase.com

$100
OFF

Series B - Iambic Therapeutics - 2023-10-03 - Crunchbase

6 days from now

Oct 3, 2023 · Iambic Therapeutics Secures $100M Series B. News • Oct 3, 2023. Venture Capital Access Online — Iambic Therapeutics Announces Close of Oversubscribed $100 Million …

crunchbase.com

$73
OFF

Cognito Therapeutics Raises $73M Series B To Advance …

6 days from now

Mar 22, 2023 · 2025 Calendar Photos. Contact Us; Subscribe; E-Edition; 70°

starkvilledailynews.com

FAQs about Series B - Cognito Therapeutics - 2023-03-22 - Crunchbase Coupon?

Does Cognito therapeutics have a series B financing?

CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. ...

How much did Cognito Therapeutics raise?

Cognito Therapeutics, $73M, biotech: Cambridge, Massachusetts-based Cognito Therapeutics, which is developing therapies to treat central nervous system diseases, closed a $73 million Series B led by FoundersX Ventures. Founded in 2016, Cognito has now raised $93 million, per the company. 7. ...

Who is Cognito Therapeutics?

About Cognito Therapeutics Cognito Therapeutics is a clinical-stage neurotechnology company developing disease-modifying therapeutic approaches to treat neurodegenerative disorders. Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. ...

Who will join Cognito's Board of directors?

In addition to the financing, Dr. Rick Kuntz, MD, MSc, former Senior Vice President, Chief Medical and Scientific Officer of Medtronic and Helen Liang, Founder & Managing Partner at FoundersX, will join Cognito’s Board of Directors. Dr. ...

Is Cognito a non-invasive neuromodulation device?

Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. The Company’s lead therapy is currently in a pivotal study in Alzheimer’s Disease and was awarded FDA Breakthrough Device Designation. Cognito is based in Cambridge, MA. ...